Digital AI in action: Report highlights the real-world benefits of A... Joined up thinking is the key to converting AI-driven advances into real benefits for healthcare systems, say NHSX.
News BioNTech to buy rival mRNA firm CureVac for $1.25bn BioNTech has agreed to buy another specialist in mRNA medicines, fellow German biotech CureVac, for around $1.25 billion.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
